This study demonstrated that the SPR domain of SPRED1 undergoes S-acylation, presumably S- palmitoylation and that several missense mutations in Legius syndrome impair the membrane localization of SPRED1 due to defective palmitoylation, leading to reduced Ras inactivation. The gene discussed is SPR; the disease is Legius syndrome.